StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Northwest Biotherapeutics's price to sales ratio was 119.2× on Oct 19, 2026, against 330.0× a year earlier. Over the last 5 years it ranged from 0.0× to 483.6×, with a median of 255.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 2026119.2×−251.5
2025Dec 31, 2025370.7×+149.2
2024Dec 31, 2024221.4×−163.2
2023Dec 29, 2023384.6×+384.6
2022Dec 30, 20220.0×−483.6
2021Dec 31, 2021483.6×+94.8
2020Oct 30, 2020388.8×+246.3
2019Jan 31, 2019142.5×+22.8
2018Dec 31, 2018119.7×+0.4
2017Dec 29, 2017119.3×+89.4
2016Dec 30, 201629.9×−113.2
2015Dec 31, 2015143.1×−344.7
2014May 30, 2014487.8×+308.9
2013Dec 31, 2013178.9×+178.8
2012Dec 31, 20120.1×−3.4
2011Dec 30, 20113.5×–

More Northwest Biotherapeutics figures

See a number that looks wrong?